Stellar Biotechnologies,
manufacturer of Keyhole Limpet Hemocyanin (KLH), an important
immune-stimulating protein used in wide-ranging therapeutic and diagnostic
markets, has retained Stonegate, Inc. to provide institutional investor
outreach and capital markets advisory for Stellar, pending regulatory approval.
“Stellar has reached a key
point of our business development and immunotherapy research program where we
believe we are well positioned to increase our institutional outreach efforts,”
Frank Oakes, president and CEO of Stellar, stated in the news release. “Our
core business of manufacture and supply of KLH protein continues to strengthen
our position to negotiate alliances with commercial partners in parallel with
their clinical successes. We continue to make breakthroughs in aquaculture
science and our immunotherapy program targeting Clostridium difficile (“C.
diff”) is on track to deliver data midsummer. These achievements coupled with
our strong financial position to support our efforts, reinforces my confidence
that we have a compelling story to tell.”
Stonegate is a 40-year old
research, capital markets advisory and investment banking boutique specializing
in small-cap public companies. The firm provides research, sales and trading,
corporate finance, strategic advisory and investor relations’ services, working
with institutional investors in the U.S. and Europe who are seeking
high-quality investment opportunities in the small-cap marketplace.
Stellar’s expectation is
that Stonegate’s history of success connecting growth companies with
institutional investors will help expand the company’s institutional awareness
and shareholder base, according to Oakes.
For more information, visit
www.stellarbiotech.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
